122 related articles for article (PubMed ID: 1551107)
1. Role of aldehyde dehydrogenase in the protection of hematopoietic progenitor cells from 4-hydroperoxycyclophosphamide by interleukin 1 beta and tumor necrosis factor.
Moreb J; Zucali JR; Zhang Y; Colvin MO; Gross MA
Cancer Res; 1992 Apr; 52(7):1770-4. PubMed ID: 1551107
[TBL] [Abstract][Full Text] [Related]
2. The role of interleukin 3 and interleukin 6 in the protection from 4-hydroperoxycyclophosphamide and the proliferation of early human hematopoietic progenitor cells.
Moreb J; Zucali JR; Weiner RS
Exp Hematol; 1989 Nov; 17(10):1022-7. PubMed ID: 2806435
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 and tumor necrosis factor alpha induce class 1 aldehyde dehydrogenase mRNA and protein in bone marrow cells.
Moreb JS; Turner C; Sreerama L; Zucali JR; Sladek NE; Schweder M
Leuk Lymphoma; 1995 Dec; 20(1-2):77-84. PubMed ID: 8750626
[TBL] [Abstract][Full Text] [Related]
4. Role for aldehyde dehydrogenase in survival of progenitors for murine blast cell colonies after treatment with 4-hydroperoxycyclophosphamide in vitro.
Sahovic EA; Colvin M; Hilton J; Ogawa M
Cancer Res; 1988 Mar; 48(5):1223-6. PubMed ID: 3342403
[TBL] [Abstract][Full Text] [Related]
5. Protection of cells capable of reconstituting long-term bone marrow stromal cultures from 4-hydroperoxycyclophosphamide by interleukin 1 and tumor necrosis factor.
Zucali JR; Moreb J; Bain C
Exp Hematol; 1992 Sep; 20(8):969-73. PubMed ID: 1505642
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitro.
Lemoli RM; Strife A; Clarkson BD; Haley JD; Gulati SC
Exp Hematol; 1992 Dec; 20(11):1252-6. PubMed ID: 1493854
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide.
Moreb J; Schweder M; Suresh A; Zucali JR
Cancer Gene Ther; 1996; 3(1):24-30. PubMed ID: 8785707
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 and tumor necrosis factor-alpha as radio- and chemoprotectors of bone marrow.
Dalmau SR; Freitas CS; Tabak DG
Bone Marrow Transplant; 1993 Dec; 12(6):551-63. PubMed ID: 8136738
[TBL] [Abstract][Full Text] [Related]
9. Protection of hematopoietic progenitors from ultraviolet C by interleukin-1 and tumor necrosis factor-alpha.
Moreb JS; Safah H; Chen M
J Interferon Cytokine Res; 1997 Jul; 17(7):395-400. PubMed ID: 9243371
[TBL] [Abstract][Full Text] [Related]
10. The effects of tumor necrosis factor-alpha on early human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide.
Moreb J; Zucali JR; Rueth S
Blood; 1990 Aug; 76(4):681-9. PubMed ID: 2383651
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of IL-1 on human hematopoietic progenitor cells treated in vitro with 4-hydroperoxycyclophosphamide.
Moreb J; Zucali JR; Gross MA; Weiner RS
J Immunol; 1989 Mar; 142(6):1937-42. PubMed ID: 2784143
[TBL] [Abstract][Full Text] [Related]
12. Effect of IL-1 and TNF-alpha on early progenitor cells: implications for bone marrow purging.
Zucali J; Moreb J; Weiner R
Bone Marrow Transplant; 1991; 7 Suppl 2():140. PubMed ID: 1878682
[No Abstract] [Full Text] [Related]
13. The role of protein kinase C in interleukin 1 and tumor necrosis factor alpha induction of fibroblasts to produce and release granulocyte-macrophage colony-stimulating activity.
Zucali JR; Morse C; Dinarello CA
Exp Hematol; 1990 Sep; 18(8):888-92. PubMed ID: 2167234
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of radiation injury to human hematopoietic stem cells with tumor necrosis factor-alpha.
Karkanitsa LV; Komarovskaya ME; Krivenko SI
Stem Cells; 1997; 15 Suppl 2():95-102. PubMed ID: 9368291
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
16. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
17. Contrasting mechanisms of the myeloprotective effects of interleukin-1 against ionizing radiation and cytotoxic 5-fluorouracil.
Neta R; Keller JR; Ali N; Blanchette F; Dubois CM
Radiat Res; 1996 May; 145(5):624-31. PubMed ID: 8619029
[TBL] [Abstract][Full Text] [Related]
18. Human N-terminal analogs of interleukin 1 beta demonstrate altered binding and function in hematopoiesis.
Zucali JR; Moreb J; Newton RC; Huaog JJ
Exp Hematol; 1990 Nov; 18(10):1078-82. PubMed ID: 2145179
[TBL] [Abstract][Full Text] [Related]
19. Expression of antisense RNA to aldehyde dehydrogenase class-1 sensitizes tumor cells to 4-hydroperoxycyclophosphamide in vitro.
Moreb JS; Maccow C; Schweder M; Hecomovich J
J Pharmacol Exp Ther; 2000 May; 293(2):390-6. PubMed ID: 10773007
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid down-regulates aldehyde dehydrogenase and increases cytotoxicity of 4-hydroperoxycyclophosphamide and acetaldehyde.
Moreb JS; Gabr A; Vartikar GR; Gowda S; Zucali JR; Mohuczy D
J Pharmacol Exp Ther; 2005 Jan; 312(1):339-45. PubMed ID: 15470086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
